OBJECTIVES: The study assessed whether heart rate (HR) reduction following an exercise stress test (ExStrT), an easily quantifiable marker of vagal reflexes, might identify high- and low-risk long QT syndrome (LQTS) type 1 (LQT1) patients. BACKGROUND: Identification of LQTS patients more likely to be symptomatic remains elusive. We have previously shown that depressed baroreflex sensitivity, an established marker of reduced vagal reflexes, predicts low probability of symptoms among LQT1. METHODS: We studied 169 LQTS genotype-positive patients < 50 years of age who performed an ExStrT with the same protocol, on and off β-blockers including 47 South African LQT1 patients all harboring the KCNQ1-A341V mutation and 122 Italian LQTS patients with impaired (I(Ks)-, 66 LQT1) or normal (I(Ks)+, 50 LQT2 and 6 LQT3) I(Ks) current. RESULTS: Despite similar maximal HR and workload, by the first minute after cessation of exercise the symptomatic patients in both I(Ks)- groups had a greater HR reduction compared with the asymptomatic (19 ± 7 beats/min vs. 13 ± 5 beats/min and 27 ± 10 beats/min vs. 20 ± 8 beats/min, both p = 0.009). By contrast, there was no difference between the I(Ks)+ symptomatic and asymptomatic patients (23 ± 9 beats/min vs. 26 ± 9 beats/min, p = 0.47). LQT1 patients in the upper tertile for HR reduction had a higher risk of being symptomatic (odds ratio: 3.28, 95% confidence interval: 1.3 to 8.3, p = 0.012). CONCLUSIONS: HR reduction following exercise identifies LQT1 patients at high or low arrhythmic risk, independently of β-blocker therapy, and contributes to risk stratification. Intense exercise training, which potentiates vagal reflexes, should probably be avoided by LQT1 patients.
OBJECTIVES: The study assessed whether heart rate (HR) reduction following an exercise stress test (ExStrT), an easily quantifiable marker of vagal reflexes, might identify high- and low-risk long QT syndrome (LQTS) type 1 (LQT1) patients. BACKGROUND: Identification of LQTS patients more likely to be symptomatic remains elusive. We have previously shown that depressed baroreflex sensitivity, an established marker of reduced vagal reflexes, predicts low probability of symptoms among LQT1. METHODS: We studied 169 LQTS genotype-positive patients < 50 years of age who performed an ExStrT with the same protocol, on and off β-blockers including 47 South African LQT1patients all harboring the KCNQ1-A341V mutation and 122 Italian LQTS patients with impaired (I(Ks)-, 66 LQT1) or normal (I(Ks)+, 50 LQT2 and 6 LQT3) I(Ks) current. RESULTS: Despite similar maximal HR and workload, by the first minute after cessation of exercise the symptomatic patients in both I(Ks)- groups had a greater HR reduction compared with the asymptomatic (19 ± 7 beats/min vs. 13 ± 5 beats/min and 27 ± 10 beats/min vs. 20 ± 8 beats/min, both p = 0.009). By contrast, there was no difference between the I(Ks)+ symptomatic and asymptomatic patients (23 ± 9 beats/min vs. 26 ± 9 beats/min, p = 0.47). LQT1patients in the upper tertile for HR reduction had a higher risk of being symptomatic (odds ratio: 3.28, 95% confidence interval: 1.3 to 8.3, p = 0.012). CONCLUSIONS:HR reduction following exercise identifies LQT1patients at high or low arrhythmic risk, independently of β-blocker therapy, and contributes to risk stratification. Intense exercise training, which potentiates vagal reflexes, should probably be avoided by LQT1patients.
Authors: J Tank; J Jordan; A Diedrich; M Stoffels; G Franke; H D Faulhaber; F C Luft; A Busjahn Journal: Hypertension Date: 2001-03 Impact factor: 10.190
Authors: Marta Tomás; Carlo Napolitano; Luciana De Giuli; Raffaella Bloise; Isaac Subirana; Alberto Malovini; Riccardo Bellazzi; Dan E Arking; Eduardo Marban; Aravinda Chakravarti; Peter M Spooner; Silvia G Priori Journal: J Am Coll Cardiol Date: 2010-06-15 Impact factor: 24.094
Authors: Maria Teresa La Rovere; Chiara Bersano; Marco Gnemmi; Giuseppe Specchia; Peter J Schwartz Journal: Circulation Date: 2002-08-20 Impact factor: 29.690
Authors: Raymond W Sy; Christian van der Werf; Ishvinder S Chattha; Priya Chockalingam; Arnon Adler; Jeffrey S Healey; Mark Perrin; Michael H Gollob; Allan C Skanes; Raymond Yee; Lorne J Gula; Peter Leong-Sit; Sami Viskin; George J Klein; Arthur A Wilde; Andrew D Krahn Journal: Circulation Date: 2011-10-31 Impact factor: 29.690
Authors: Sami Viskin; Pieter G Postema; Zahurul A Bhuiyan; Raphael Rosso; Jonathan M Kalman; Jitendra K Vohra; Milton E Guevara-Valdivia; Manlio F Marquez; Evgeni Kogan; Bernard Belhassen; Michael Glikson; Boris Strasberg; Charles Antzelevitch; Arthur A M Wilde Journal: J Am Coll Cardiol Date: 2010-01-29 Impact factor: 24.094
Authors: P J Schwartz; S G Priori; C Spazzolini; A J Moss; G M Vincent; C Napolitano; I Denjoy; P Guicheney; G Breithardt; M T Keating; J A Towbin; A H Beggs; P Brink; A A Wilde; L Toivonen; W Zareba; J L Robinson; K W Timothy; V Corfield; D Wattanasirichaigoon; C Corbett; W Haverkamp; E Schulze-Bahr; M H Lehmann; K Schwartz; P Coumel; R Bloise Journal: Circulation Date: 2001-01-02 Impact factor: 29.690
Authors: Alberto Porta; Giulia Girardengo; Vlasta Bari; Alfred L George; Paul A Brink; Althea Goosen; Lia Crotti; Peter J Schwartz Journal: J Am Coll Cardiol Date: 2015-02-03 Impact factor: 24.094
Authors: Peter J Schwartz; Michael J Ackerman; Charles Antzelevitch; Connie R Bezzina; Martin Borggrefe; Bettina F Cuneo; Arthur A M Wilde Journal: Nat Rev Dis Primers Date: 2020-07-16 Impact factor: 52.329